# SODIUM NITROPRUSSIDE
> **ANDA211016** · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2019-11-29
## Drug
- **FDA Application Number:** ANDA211016
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM NITROPRUSSIDE
- **Generic name:** SODIUM NITROPRUSSIDE
- **Active ingredients:** SODIUM NITROPRUSSIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** CAPLIN
- **Manufacturer:** Meitheal Pharmaceuticals Inc.
- **First approval:** 2019-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211016)
---
*AI Analytics · CC0 1.0*